128 142

Cited 3 times in

Intravitreal Bevacizumab for the Treatment of Optic Disc Edema in a Patient with POEMS Syndrome

DC FieldValueLanguage
dc.contributor.author김도욱-
dc.contributor.author김찬윤-
dc.contributor.author배형원-
dc.contributor.author성공제-
dc.contributor.author홍사민-
dc.date.accessioned2018-03-26T17:12:45Z-
dc.date.available2018-03-26T17:12:45Z-
dc.date.issued2015-
dc.identifier.issn1011-8942-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/157350-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherKJO-
dc.relation.isPartOfKorean Journal of Ophthalmology-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAngiogenesis Inhibitors/administration & dosage-
dc.subject.MESHBevacizumab/administration & dosage*-
dc.subject.MESHFemale-
dc.subject.MESHFluorescein Angiography-
dc.subject.MESHFollow-Up Studies-
dc.subject.MESHFundus Oculi-
dc.subject.MESHHumans-
dc.subject.MESHIntravitreal Injections-
dc.subject.MESHOptic Disk/pathology*-
dc.subject.MESHPOEMS Syndrome/complications*-
dc.subject.MESHPOEMS Syndrome/diagnosis-
dc.subject.MESHPapilledema/diagnosis-
dc.subject.MESHPapilledema/drug therapy*-
dc.subject.MESHPapilledema/etiology-
dc.titleIntravitreal Bevacizumab for the Treatment of Optic Disc Edema in a Patient with POEMS Syndrome-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Ophthalmology-
dc.contributor.googleauthorDo Wook Kim-
dc.contributor.googleauthorSung Yong Kang-
dc.contributor.googleauthorHyoung Won Bae-
dc.contributor.googleauthorSamin Hong-
dc.contributor.googleauthorGong Je Seong-
dc.contributor.googleauthorChan Yun Kim-
dc.identifier.doi10.3341/kjo.2015.29.5.354-
dc.contributor.localIdA04518-
dc.contributor.localIdA01035-
dc.contributor.localIdA01814-
dc.contributor.localIdA01946-
dc.contributor.localIdA04395-
dc.relation.journalcodeJ02931-
dc.identifier.eissn2092-9382-
dc.identifier.pmid26457044-
dc.subject.keywordAdult-
dc.subject.keywordAngiogenesis Inhibitors/administration & dosage-
dc.subject.keywordBevacizumab/administration & dosage*-
dc.subject.keywordFemale-
dc.subject.keywordFluorescein Angiography-
dc.subject.keywordFollow-Up Studies-
dc.subject.keywordFundus Oculi-
dc.subject.keywordHumans-
dc.subject.keywordIntravitreal Injections-
dc.subject.keywordOptic Disk/pathology*-
dc.subject.keywordPOEMS Syndrome/complications*-
dc.subject.keywordPOEMS Syndrome/diagnosis-
dc.subject.keywordPapilledema/diagnosis-
dc.subject.keywordPapilledema/drug therapy*-
dc.subject.keywordPapilledema/etiology-
dc.contributor.alternativeNameKim, Do Wook-
dc.contributor.alternativeNameKim, Chan Yun-
dc.contributor.alternativeNameBae, Hyoung Won-
dc.contributor.alternativeNameSeong, Gong Je-
dc.contributor.alternativeNameHong, Sa Min-
dc.contributor.affiliatedAuthorKim, Do Wook-
dc.contributor.affiliatedAuthorKim, Chan Yun-
dc.contributor.affiliatedAuthorBae, Hyoung Won-
dc.contributor.affiliatedAuthorSeong, Gong Je-
dc.contributor.affiliatedAuthorHong, Sa Min-
dc.citation.volume29-
dc.citation.number5-
dc.citation.startPage354-
dc.citation.endPage356-
dc.identifier.bibliographicCitationKorean Journal of Ophthalmology, Vol.29(5) : 354-356, 2015-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.